Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 36 (5) , 475-479
- https://doi.org/10.1016/0026-0495(87)90046-1
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- HUMAN APOLIPOPROTEIN MOLECULAR BIOLOGY AND GENETIC VARIATIONAnnual Review of Biochemistry, 1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Atherogenic Hyperlipoproteinemia: The Cellular and Molecular Biology of Plasma Lipoproteins Altered by Dietary Fat and CholesterolMedical Clinics of North America, 1982
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Regulation of Plasma Cholesterol by Lipoprotein ReceptorsScience, 1981
- A simple colorimetric method for determination of serum triglycerides with lipoprotein lipase and glycerol dehydrogenaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by achilles' tendon thicknessAtherosclerosis, 1977